Effects of Eptifibatide and Abciximab on Smooth Muscle Cell Responses to Insulin
Author Information
Author(s): Pathak Alokkumar, Zhao Renyi, Huang Jianhua, Stouffer George A
Primary Institution: University of North Carolina, Chapel Hill, NC, USA
Hypothesis
Abciximab and eptifibatide inhibit proliferative responses of human aortic smooth muscle cells to insulin via antagonizing αvβ3 integrins.
Conclusion
The study found that αvβ3 antagonists significantly inhibit insulin-induced proliferation and focal adhesion formation in human aortic smooth muscle cells.
Supporting Evidence
- Insulin increased cell proliferation in a dose-dependent manner.
- Abciximab and eptifibatide significantly inhibited insulin-induced proliferation.
- Focal adhesion formation was completely inhibited by m7E3 and significantly reduced by eptifibatide.
Takeaway
This study shows that certain drugs can stop heart cells from growing too much when they get a signal from insulin, which is important for people with diabetes.
Methodology
The study involved cell culture, proliferation assays, flow cytometric analysis, and various treatments with integrin inhibitors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website